Here are my latest thoughts....
I believe we are due an update before the Sept applications are approved, specifically how they will operate & fund Galactica and Pegasus and even Voyager. My view is that they should be looking at other commercial pathways given the current SP value, and avoid the need for too much funding by cap raise. With the opportunity of circa 50K rev per day or circa $1.5M p/month, there is room to move on funding sources. The amount of money required to be raised through a cap raise should be a small as possible.
We already know they will obtain $2M - $3M p/a from Sammons with a $1.3M investment generating circa $250K per month.
I don't think because mgt hasn't bought any shares lately is necessary a reflection on the company performance or future performance. You don't know their personal situation, and I wouldn't even begin to assume.
- Forums
- ASX - By Stock
- BNL
- Ann: Significant Helium Discovery at State 16 Well
BNL
blue star helium limited
Add to My Watchlist
0.00%
!
0.6¢

Ann: Significant Helium Discovery at State 16 Well, page-188
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $16.16M |
Open | High | Low | Value | Volume |
0.6¢ | 0.6¢ | 0.6¢ | $4.462K | 743.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
21 | 6408631 | 0.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.6¢ | 3429779 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
21 | 6408631 | 0.005 |
32 | 23471029 | 0.004 |
11 | 16652335 | 0.003 |
5 | 19780000 | 0.002 |
5 | 29805000 | 0.001 |
Price($) | Vol. | No. |
---|---|---|
0.006 | 3429779 | 10 |
0.007 | 7433351 | 18 |
0.008 | 9496296 | 27 |
0.009 | 4608008 | 10 |
0.010 | 3271005 | 6 |
Last trade - 10.58am 04/07/2025 (20 minute delay) ? |
Featured News
BNL (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online